Correlation Between RenovoRx and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Inozyme Pharma, you can compare the effects of market volatilities on RenovoRx and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Inozyme Pharma.
Diversification Opportunities for RenovoRx and Inozyme Pharma
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between RenovoRx and Inozyme is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of RenovoRx i.e., RenovoRx and Inozyme Pharma go up and down completely randomly.
Pair Corralation between RenovoRx and Inozyme Pharma
Given the investment horizon of 90 days RenovoRx is expected to generate 1.41 times more return on investment than Inozyme Pharma. However, RenovoRx is 1.41 times more volatile than Inozyme Pharma. It trades about 0.03 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.08 per unit of risk. If you would invest 127.00 in RenovoRx on August 26, 2024 and sell it today you would earn a total of 2.00 from holding RenovoRx or generate 1.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Inozyme Pharma
Performance |
| Timeline |
| RenovoRx |
| Inozyme Pharma |
RenovoRx and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Inozyme Pharma
The main advantage of trading using opposite RenovoRx and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |